玻璃酸钠联合氨基葡萄糖治疗膝关节骨性关节炎的临床观察

摘要

OBJECTIVE:To observe the clinical efficacy and safety of sodium hyaluronate combined with glucosamine in the treatment of knee osteoarthritis. METHODS:1 220 patients with knee osteoarthritis were randomly divided into observation group and control group. The patients in control group were treated with Sodium hyaluronate injection alone,once a week;while the ob-servation group was additionally and orally treated with Glucosamine hydrochloride capsules two tablets,three times a day. The course of treatment was 5 weeks in both groups. The relevant physicotherapeutics and oral medication in the treatment of the dis-ease should be stopped. The clinic efficacy,visual analog scale(VAS)and lysholm knee score before and after treatment,and inci-dence of adverse reaction were observed. RESULTS:Total effective rate of observation group was significantly higher than control group,with statistically significant difference(P<0.05). After treatment,VAS and lysholm knee scores in both groups were signifi-cantly lower than before,and observation group was lower than control group,with significant differences(P<0.05). There were no severe adverse reactions during treatment. CONCLUSIONS:Sodium hyaluronate combined with glucosamine has more signifi-cant clinical efficacy in the treatment of knee osteoarthritis than sodium hyaluronate alone,with good safety.%目的：观察玻璃酸钠联合氨基葡萄糖治疗膝关节骨性关节炎的临床疗效和安全性。方法：1220例膝关节骨性关节炎患者随机均分为对照组与观察组。对照组患者给予玻璃酸钠注射液进行关节腔内注射治疗，每周1次；观察组患者在对照组治疗的基础上给予盐酸氨基葡萄糖胶囊2粒，口服，每日3次。两组患者疗程均为5周。治疗期间均停用与本研究相关的局部物理治疗及口服药物。观察两组患者的临床疗效，治疗前后视觉模拟（VAS）评分、Lysholm膝关节评分及不良反应发生情况。结果：观察组患者总有效率显著高于对照组，差异有统计学意义（P＜0.05）。治疗后，两组患者VAS评分、Lysholm膝关节评分均显著低于同组治疗前，且观察组低于对照组，差异均有统计学意义（P＜0.05）。两组患者治疗期间均未见严重不良反应发生。结论：玻璃酸钠联合氨基葡萄糖治疗膝关节骨性关节炎较单用玻璃酸钠疗效更显著，安全性较好。